Results 161 to 170 of about 8,454 (202)
Outcomes after treatment with proton pump inhibitors in patients with ineffective esophageal motility: a systematic review. [PDF]
Gastroenterol Hepatol Bed BenchSakr F +5 more
europepmc +1 more source
Site-specific activation of the proton pump inhibitor rabeprazole by tetrathiolate zinc centres. [PDF]
Nat ChemMarker T +13 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Drugs, 1998
Rabeprazole is a proton pump inhibitor with antisecretory properties. In vitro animal experiments have indicated that the inhibition of the proton pump by rabeprazole is partially reversible. Rabeprazole has 2- to 10-fold greater antisecretory activity than omeprazole in vitro.
A, Prakash, D, Faulds
+5 more sources
Rabeprazole is a proton pump inhibitor with antisecretory properties. In vitro animal experiments have indicated that the inhibition of the proton pump by rabeprazole is partially reversible. Rabeprazole has 2- to 10-fold greater antisecretory activity than omeprazole in vitro.
A, Prakash, D, Faulds
+5 more sources